Purchases and Sales Made in Q3 2023 in Compass Therapeutics, Inc. (CMPX)
This table provides information about the institutional ownership of Compass Therapeutics, Inc. (CMPX) during Q3 2023. The information is specifically focused on institutions that hold shares of Compass Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2023
Q3 2023
|
Algert Global LLC
San Francisco, CA |
SELL
|
- |
-54.9K- 61.77% |
$103K - $178K
|
34K
$54K
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-55.6K- 46.77% |
$104K - $181K
|
63.3K
$101K
|
|
|
Nov 13, 2023
Q3 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-58.6K- 0.97% |
$110K - $190K
|
5.97M
$9.5M
|
|
|
Nov 13, 2023
Q3 2023
|
Foresite Capital Management V, LLC
Larkspur, CA |
SELL
|
- |
-77.1K- 5.82% |
$144K - $251K
|
1.25M
$1.98M
|
|
|
Nov 14, 2023
Q3 2023
|
Prosight Management, LP
Dallas, TX |
SELL
|
- |
-149K- 13.73% |
$278K - $484K
|
935K
$1.49M
|
|
|
Nov 13, 2023
Q3 2023
|
Monashee Investment Management LLC
Boston, MA |
SELL
|
- |
-743K- 37.74% |
$1.39M - $2.42M
|
1.23M
$1.95M
|